We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Not all periodic reports contained a narrative summary and analysis of the information in the report, an analysis of the postmarketing 15-day alert reports submitted during the reporting interval, and an FDA Form 3500A for each adverse drug experience not reported as a postmarketing 15-day Alert report.